文献速递瓣膜外科

2298例Trifecta主动脉瓣生物瓣的耐久性与性能:倾向匹配分析

Durability and Performance of 2298 Trifecta Aortic Valve Prostheses: A Propensity-Matched Analysis.
PubMed 文献 · Ann Thorac Surg · 2020-10-01

Trifecta早期跨瓣平均压差更低(1年11 vs 15 mm Hg),但压差上升更快、5年压差达17 vs 16 mm Hg,重度主动脉瓣反流更多(2.4% vs 0.81%),5年免于 explant 率更低(95.9% vs 98.7%)。结论提示尽管早期血流动力学优良,Trifecta长期耐久性令人担忧。

要点

  • Trifecta瓣早期跨瓣压差优于PERIMOUNT瓣,但压差随时间的上升速度更快。
  • Trifecta瓣重度主动脉瓣反流发生率高于PERIMOUNT瓣(2.4% vs 0.81%)。
  • 5年免于 explant 率Trifecta低于PERIMOUNT(95.9% vs 98.7%),需关注长期耐久性。

核心结论

  • 与老一代内装牛心包瓣PERIMOUNT相比,Trifecta外包裹生物瓣早期血流动力学更优,但跨瓣压差快速升高、主动脉瓣反流更多,5年免于 explant 率更低。
  • 这些发现提示尽管Trifecta早期血流动力学良好,其长期耐久性仍令人担忧。

研究设计与样本

  • 通过4971份经胸超声心动图评估术后瓣膜血流动力学趋势,并经系统随访记录瓣膜 explant。
  • 将2298例Trifecta患者与17281例PERIMOUNT患者按1:1倾向匹配比较结局。

主要发现

  • 匹配后两组植入时平均年龄均为69岁。
  • Trifecta早期跨瓣平均压差低于PERIMOUNT(1年11 vs 15 mm Hg,P < .001),但纵向上升速度更快(P < .001)。
  • 5年时平均压差为17 vs 16 mm Hg,Trifecta组重度主动脉瓣反流更多(2.4% vs 0.81%;P < .001)。
  • 5年内Trifecta组35例、PERIMOUNT组14例发生 explant。
  • 1、3、5年免于 explant 率Trifecta组分别为98.9%、98.0%、95.9%,PERIMOUNT组分别为99.3%、99.0%、98.7%(P < .001)。

关键数值与推荐

  • Trifecta vs PERIMOUNT:1年跨瓣平均压差11 vs 15 mm Hg(P < .001)。
  • 5年跨瓣平均压差17 vs 16 mm Hg。
  • 重度主动脉瓣反流2.4% vs 0.81%(P < .001)。
  • 5年免于 explant 率95.9% vs 98.7%(P < .001)。

临床怎么用

  • 主动脉瓣置换选择Trifecta生物瓣时,应权衡其早期血流动力学优势与长期压差上升、反流及 explant 风险。
  • 术后随访中需关注跨瓣压差变化趋势与主动脉瓣反流,及早识别瓣膜功能不良。

局限性

  • 为单中心回顾性研究,对照为老一代内装牛心包瓣PERIMOUNT,结论外推需谨慎。
  • 原文摘要未报告随访完整率、 explant 原因构成及多变量校正等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reports of early failure of the Trifecta externally wrapped, bovine pericardial aortic valve prosthesis (Abbott Laboratories, Abbott Park, IL) raise concerns about its durability. This study evaluated the hemodynamic performance and explant of Trifecta valves compared with the PERIMOUNT bovine pericardial prosthesis (Edwards Lifesciences, Irvine, CA). METHODS: From October 2007 to July 2017, 2305 patients received a Trifecta bioprosthesis during aortic valve replacement at Cleveland Clinic. Trends in postoperative valve hemodynamics were assessed from 4971 transthoracic echocardiograms and valve explants by systemic follow-up. To compare outcomes, 2298 patients receiving a Trifecta valve were 1:1 propensity matched from 17,281 patients receiving a PERIMOUNT bioprosthesis. RESULTS: Mean age at implant was 69 years in both matched groups. Compared with PERIMOUNT valves, early transvalvular mean gradient of Trifecta valves was lower (11 vs 15 mm Hg at 1 year, P < .001); however, its longitudinal rate of rise was greater (P < .001), resulting in 5-year mean gradients of 17 vs 16 mm Hg, and more patients experienced severe aortic regurgitation (2.4% vs 0.81%; P < .001). At 5 years, 35 Trifecta valves had been explanted vs 14 PERIMOUNT valves; freedom from explant at 1, 3, and 5 years was 98.9%, 98.0%, and 95.9%, respectively, for the Trifecta group vs 99.3%, 99.0%, and 98.7% for the PERIMOUNT group (P < .001). CONCLUSIONS: Compared with an older-generation internally mounted bovine pericardial valve, the Trifecta externally wrapped bioprosthesis exhibits superior early hemodynamic performance, but has a rapid increase in transvalvular gradient and more aortic regurgitation, with lower freedom from explant at 5 years. These findings raise concern regarding long-term Trifecta durability despite favorable early hemodynamics.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yongue C, Lopez DC, Soltesz EG, et al. Durability and Performance of 2298 Trifecta Aortic Valve Prostheses: A Propensity-Matched Analysis. Ann Thorac Surg. 2020. PMID: 33011168. doi:10.1016/j.athoracsur.2020.07.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。